Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-16,100
Closed -$4.5M 2199
2025
Q2
$4.5M Sell
16,100
-800
-5% -$227K 0.01% 1092
2025
Q1
$5.27M Sell
16,900
-800
-5% -$236K 0.01% 1003
2024
Q4
$4.61M Sell
17,700
-6,400
-27% -$1.9M 0.01% 1045
2024
Q3
$7.77M Buy
24,100
+10,100
+72% +$3.3M 0.02% 848
2024
Q2
$4.37M Buy
14,000
+9,500
+211% +$2.79M 0.01% 1051
2024
Q1
$1.28M Buy
4,500
+2,500
+125% +$732K ﹤0.01% 1463
2023
Q4
$576K Buy
+2,000
New +$545K ﹤0.01% 1630

Other funds holding AMGN

Man Group's AMGN Position: Q1 2026 in Review

Man Group reduced its Amgen (AMGN) stake by 46% in Q1 2026, selling an estimated $43.8M and leaving 142,525 shares worth $50.1M. The position accounts for 0.09% of the portfolio, ranked #239.

Man Group first reported a position in AMGN in Q1 2018 and has held it in 30 quarters since. The position peaked at $244M in Q3 2018. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Man Group held 142,525 shares of Amgen worth $50.1M as of Q1 2026.
  • Man Group sold 122,859 Amgen shares in Q1 2026, an estimated $43.8M.
  • Amgen made up 0.09% of Man Group's portfolio in Q1 2026, its #239 holding.
  • Man Group first reported a position in Amgen in Q1 2018 and has held it in 30 quarters since.
  • Man Group's Amgen position peaked at $244M in Q3 2018.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Man Group's 13F filing for Q1 2026, filed 15 May 2026.